A point mutation associated with a severe phenotype of neurofibromatosis 2

Annals of Neurology

Volumn 40, Issue 3, 1996, Pages 440-445

  MacCollin, M ^a   Braverman, N ^b   Viskochil, D ^d   Ruttledge, M ^e   Davis, Kevin ^a   Ojemann, R ^a   Gusella, J ^a   Parry, D M ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GENETIC ANALYSIS; HUMAN; HUMAN CELL; NEUROFIBROMATOSIS; NONSENSE MUTATION; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0029787583     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400313     Document Type: Article

References (29)

1. Parry D, Eldridge R, Kaiser-Kupfer M, et al. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 1994;52:450-461
2. Evans DGR, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Q J Med 1992;304;603-618
3. Kaiser-Kupfer M, Freidlin V, Datiles M, et al. The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2. Arch Ophthalmol 1989;541-544
4. Bouzas E, Parry D, Eldridge R, Kaiser-Kupfer M. Visual impairment in patients with neurofibromatosis 2. Neurology 1993;43:622-623
5. Trofatter J, MacCollin M, Rutter J, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993;72:791-800
6. Rouleau G, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993;363:515-521
7. Jacoby L, MacCollin M, Louis D, et al. Exon scanning for mutation of the NF2 gene is schwannomas. Hum Mol Genet 1994;3:413-419
8. Wellenreuther R, Kraus J, Lenartz D, et al. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 1995;146:827-832
9. Rubio MP, Correa K, Ramesh V, et al. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res 1994;54:45-47
10. MacCollin M, Ramesh V, Jacoby L, et al. Mutational analysis of patients with neurofibromatosis 2. Am J Hum Genet 1994; 55:314-320
11. Merel P, Hoang-Xuan K, Sanson M, et al. Screening for germline mutations in the NF2 gene, Genes Chromosomes Cancer 1995;12:117-127
12. Bourn D, Carter S, Mason S, et al. Germline mutations in the neurofibromatosis type 2 tumour suppressor gene. Hum Mol Genet 1994;3:813-816
13. Carey J, Lant J, Hall B. Penetrance and variability in neurofibromatosis: a genetic study of 60 families. Birth Defects 1979; 15:271-281
14. Easton D, Ponder M, Huson S, Ponder B. An analysis of variation in expression of neurofibromatosis (NF) type I (NFI): evidence for modifying genes. Am J Hum Genet 1993;53:305-313
15. Parry D, MacCollin M, Pulaski K, et al. Searching for correlations between clinical subtypes and genotypes in neurofibromatosis 2 (NF2). Neurology 1995;45(suppl 4):A440-A441 (Abstract)
16. Andermann A, Ruttledge M, Rangaratnam S, Rouleau G. Screening for germline mutations in the neurofibromatosis type 2 (NF2) gene in NF2 patients. Am J Hum Genet 1994; 55(suppl):A209 (Abstract)
17. Sainz J, Figueroa K, Baser M, et al. High frequency of nonsense mutations in the NF2 gene caused by C to T transitions in five CGA codons. Hum Mol Genet 1995;4:137-139
18. Kayes L, Burke W, Riccardi V, et al. Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. Am J Hum Genet 1994;54:424-436
19. Onadim Z, Hogg A, Baird P, Cowell J. Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype. Proc Natl Acad Sci USA 1992;89:6177-6181
20. Blanquet V, Turleau C, Gross-Morand MS, et al. Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma. Hum Mol Genet 1995;4:383-388
21. Nagase H, Miyoshi Y, Horii A, et al. Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res 1992;52:4055-4057
22. Spiro L, Olschwang S, Groden J, et al. Alleles of the APC gene: an attenuated form of familial polyposis. Cell 1993;75: 951-957
23. Olschwang S, Tiret A, Laurent-Puig P, et al. Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 1993;75:959-968
24. Crossey P, Richards F, Foster K, et al. Identification of intragenic mutations in the Von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet 1994;3:1303-1308
25. Chen F, Kishida T, Yao M, et al. Germline mutations in the Von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 1995;5:66-75
26. MacCollin M, Mohney T, Trofatter J, et al. DNA diagnosis of neurofibromatosis 2: altered coding sequence of the merlin tumor suppressor in an extended pedigree. JAMA 1993;270: 2316-2320
27. Evans DGR, Bourn D, Wallace, A, et al. Diagnostic issues in a family with late onset type 2 neurofibromatosis. J Med Genet 1995;32:470-474
28. Bourn D, Carter SA, Evans DGR, et al. A mutation in the neurofibromatosis type 2 tumor-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals. Am J Hum Genet 1994;55:69-73
29. Watson CJ, Gaunt L, Evans G, et al. A disease-associated germline deletion maps the type 2 neurofibromatosis (NF2) gene between the Ewing sarcoma region and the leukaemia inhibitory factor locus. Hum Mol Genet 1993;2:701-704